Cerebrozen Ingredients: What’s Listed and What the Evidence Says
Here are the ingredients Cerebrozen currently highlights, plus the key questions about dosing, safety and evidence that a sales page cannot answer by ingredient count alone.
Ingredients the merchant currently highlights
The Cerebrozen order page says the formula contains more than 20 ingredients and calls out eight by name. The list below reflects the public sales-page text we reviewed on September 22, 2026; the product label should remain the final source for what is actually in the bottle you receive.
| Highlighted ingredient | How the merchant describes it | Evidence-aware context |
|---|---|---|
| GABA | Relaxation support | Marketing rationale does not establish a hearing or tinnitus benefit. |
| Vinpocetine | Memory and cerebral circulation | FDA says it has not evaluated vinpocetine as effective for promoted uses and warns pregnant women and women who could become pregnant to avoid it. |
| Lion’s Mane Powder | Hearing support | Direct clinical evidence for tinnitus or hearing-loss treatment is not established. |
| Alpha GPC | Cognitive function and memory | A cognitive-support rationale is different from evidence for auditory outcomes. |
| Ginkgo biloba | Neuroprotective properties | Cochrane found no evidence that ginkgo improves tinnitus compared with placebo; NCCIH also says it has not been shown to relieve tinnitus. |
| Coenzyme Q10 | Energy support | General cellular-energy claims do not prove an effect on tinnitus or hearing loss. |
| Lemon extract | Antioxidant support | Antioxidant rationale is not the same as demonstrated clinical efficacy for hearing symptoms. |
| Magnesium citrate | Energy support | Its presence does not establish that the finished product changes hearing outcomes. |
What the sales page does not make easy to evaluate
The public text names ingredients but does not show, in text, the amount of each highlighted ingredient per serving. Dose matters. A study involving a specific ingredient at a specific amount cannot reliably support a different dose or a multi-ingredient blend unless the formulation itself has been tested.
Vinpocetine deserves special attention
FDA describes vinpocetine as a synthetically produced compound and says it has not evaluated whether vinpocetine is effective for the various uses for which it is marketed. FDA also advises pregnant women and women who could become pregnant not to take vinpocetine because of possible miscarriage or harm to fetal development.
That warning is especially important here because vinpocetine appears directly in the ingredient list highlighted on the Cerebrozen sales page.
Ginkgo biloba: popular, but not proven for tinnitus
Ginkgo is one of the most familiar ingredients in the hearing-supplement category. Familiarity should not be confused with efficacy. A Cochrane review found no evidence that ginkgo improves tinnitus compared with placebo. NCCIH similarly reports that research does not show ginkgo to relieve tinnitus and notes potential interactions with anticoagulant drugs.
Does “more than 20 ingredients” make a formula stronger?
Not necessarily. Ingredient count can broaden the marketing story, but clinical usefulness depends on the identity, amount, quality, interactions and evidence for each ingredient—and ideally on evidence for the finished formula. A shorter formula with clear dosing can sometimes be easier to evaluate than a longer formula with incomplete dose disclosure.
How the formula fits the product’s positioning
Cerebrozen combines ingredients commonly associated in supplement marketing with circulation, antioxidants, cognition, energy and stress support. That helps explain the brand’s “hearing + mental sharpness” positioning. It does not, by itself, prove the formula improves a medical hearing condition.
